Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm
Maria A. Garcia, Paula Barreras, Allie Lewis, Gabriel Pinilla, Lori J. Sokoll, Thomas S. Kickler, Heba H. Mostafa, Mario Caturegli, Abhay Moghekar, Kathryn C. Fitzgerald, Carlos A. Pardo
Topics & Concepts
MedicineCerebrospinal fluidImmunologyViral meningitisCytokine stormInterleukin 6CytokineAntibodyCoronavirus disease 2019 (COVID-19)Internal medicineBacterial meningitisInfectious disease (medical specialty)DiseaseLong-Term Effects of COVID-19Neuroinflammation and Neurodegeneration MechanismsCOVID-19 Clinical Research Studies